A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer. [electronic resource]
Producer: 20040812Description: 585-9 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- adverse effects
- Breast Neoplasms -- drug therapy
- Colony-Forming Units Assay
- Docetaxel
- Drug Therapy, Combination
- Female
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Hematopoietic Stem Cells -- drug effects
- Humans
- Middle Aged
- Neutropenia -- chemically induced
- Taxoids -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.